H. Meden

1.5k total citations
68 papers, 1.0k citations indexed

About

H. Meden is a scholar working on Oncology, Reproductive Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, H. Meden has authored 68 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 20 papers in Reproductive Medicine and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in H. Meden's work include Ovarian cancer diagnosis and treatment (19 papers), HER2/EGFR in Cancer Research (15 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). H. Meden is often cited by papers focused on Ovarian cancer diagnosis and treatment (19 papers), HER2/EGFR in Cancer Research (15 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). H. Meden collaborates with scholars based in Germany, Switzerland and Spain. H. Meden's co-authors include Walter Kühn, A. Schauer, D Marx, W. Kühn, Martina Kron, Walther Kuhn, Alfred Schauer, J. Schneider, Elisa Jiménez and W. Wuttke and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer.

In The Last Decade

H. Meden

63 papers receiving 983 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Meden Germany 19 492 355 288 216 146 68 1.0k
Berno Tanner Germany 16 423 0.9× 503 1.4× 427 1.5× 165 0.8× 195 1.3× 27 1.1k
Herbert L. Kotz United States 13 363 0.7× 429 1.2× 286 1.0× 62 0.3× 128 0.9× 24 1.0k
Yuji Yaginuma Japan 19 424 0.9× 646 1.8× 117 0.4× 49 0.2× 208 1.4× 51 1.2k
Claus Lattrich Germany 18 508 1.0× 355 1.0× 155 0.5× 51 0.2× 328 2.2× 49 1.1k
Qianming Bai China 20 314 0.6× 412 1.2× 72 0.3× 183 0.8× 203 1.4× 82 1.2k
Gary L. Goldberg United States 17 303 0.6× 416 1.2× 183 0.6× 29 0.1× 108 0.7× 33 867
Verena Materna Germany 20 632 1.3× 552 1.6× 155 0.5× 32 0.1× 220 1.5× 33 1.1k
Dineo Khabele United States 22 450 0.9× 847 2.4× 362 1.3× 33 0.2× 168 1.2× 54 1.6k
Vincenzo Sforza Italy 18 680 1.4× 380 1.1× 53 0.2× 61 0.3× 194 1.3× 58 1.2k
Lin Guo China 21 332 0.7× 731 2.1× 146 0.5× 55 0.3× 440 3.0× 71 1.3k

Countries citing papers authored by H. Meden

Since Specialization
Citations

This map shows the geographic impact of H. Meden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Meden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Meden more than expected).

Fields of papers citing papers by H. Meden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Meden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Meden. The network helps show where H. Meden may publish in the future.

Co-authorship network of co-authors of H. Meden

This figure shows the co-authorship network connecting the top 25 collaborators of H. Meden. A scholar is included among the top collaborators of H. Meden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Meden. H. Meden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wöckel, Achim, et al.. (2021). Treatment of Vulvovaginal Atrophy with Fractional CO 2 Laser: Evaluating Real-World Data. Photobiomodulation Photomedicine and Laser Surgery. 39(11). 716–724. 3 indexed citations
2.
3.
Zepelin, Hans‐Heinrich Henneicke‐von, et al.. (2007). Isopropanolic black cohosh extract and recurrence-free survival after breast cancer. International Journal of Clinical Pharmacology and Therapeutics. 45(3). 143–154. 50 indexed citations
4.
Meden, H., et al.. (2003). Differential Expression of Apoptosis-Associated Genes baxand bcl-2 in Ovarian Cancer. Humana Press eBooks. 17(3C). 687–691. 29 indexed citations
5.
Meden, H., et al.. (2001). Weekly intravenous recombinant humanized anti-P185HER2 monoclonal antibody (herceptin) plus docetaxel in patients with metastatic breast cancer: a pilot study.. PubMed. 21(2B). 1301–5. 35 indexed citations
6.
Kühn, W, et al.. (1998). Detection of p105 (c-erbB-2, HER2/neu) serum levels by a new ELISA in patients with ovarian carcinoma.. PubMed. 18(4B). 2891–4. 14 indexed citations
7.
Meden, H., et al.. (1998). Expression of the p53 tumour suppressor gene as a prognostic marker in platinum-treated patients with ovarian cancer. European Journal of Cancer. 34(6). 845–850. 31 indexed citations
8.
Meden, H., et al.. (1997). Hormonal treatment with sex steroids in women is associated with lower p105 serum concentrations.. PubMed. 17(4B). 3075–7. 13 indexed citations
9.
Mielke, Stephan, et al.. (1997). In vivoeffects of estrogens on oerbB-2 oncoprotein levels in chorionic villous tissue and maternal serum. Gynecological Endocrinology. 11(4). 237–241. 2 indexed citations
10.
Meden, H., Stephan Mielke, A. Schauer, & Walter Kühn. (1997). Serum levels of the c-erbB-2 (HER2/neu) encoded oncoprotein fragment p105 in normal pregnancies.. PubMed. 11(1). 51–4. 16 indexed citations
11.
Meden, H., D Marx, A. Schauer, W. Wuttke, & Walter Kühn. (1997). Prognostic significance of p105 (c-erbB-2 HER2/neu) serum levels in patients with ovarian cancer.. PubMed. 17(1B). 757–60. 25 indexed citations
12.
Niedmann, P. D., et al.. (1997). A Simple and Reliable Reverse-Phase High-Performance Liquid Chromatographic Procedure for Determination of Paclitaxel (Taxol) in Human Serum. Therapeutic Drug Monitoring. 19(3). 327–332. 17 indexed citations
13.
14.
Meden, H., et al.. (1995). A clinical, mammographic, sonographic and histologic evaluation of breast cancer. International Journal of Gynecology & Obstetrics. 48(2). 193–199. 18 indexed citations
15.
Meden, H., Martin Busch, Ute Bartels, et al.. (1994). Experience with a New Flexible Applicator System for Intracavitary Radiotherapy of Cervical Cancer. Oncology Research and Treatment. 17(6). 604–607. 1 indexed citations
16.
Meden, H., D Marx, Martina Kron, et al.. (1994). Overexpression of the Oncogene c-erb B2 in Primary Ovarian Cancer. International Journal of Gynecological Pathology. 13(1). 45–53. 73 indexed citations
17.
Meden, H., Werner Rath, & W. Kühn. (1994). Taxol - ein neues Zytostatikum zur Therapie des Ovarial- und Mammakarzinoms. Geburtshilfe und Frauenheilkunde. 54(4). 187–193. 5 indexed citations
18.
Meden, H., et al.. (1990). Die Wertigkeit der präoperativen Diagnostik vor der Second-look-Laparotomie beim Ovarialkarzinom*. Geburtshilfe und Frauenheilkunde. 50(2). 101–105. 3 indexed citations
19.
Meden, H., W Rath, A. Teíchmann, & W. Kühn. (1989). Serumspiegel des Tumormarkers CA 125 vor der Second-look-Laparotomie beim primären epithelialen Ovarialkarzinom in Relation zu intraoperativen Befunden. Oncology Research and Treatment. 12(5). 217–220. 1 indexed citations
20.
Meden, H. & W Rath. (1989). Kongenitale Hyperthyreose bei maternalem Morbus Basedow. Geburtshilfe und Frauenheilkunde. 49(9). 822–824. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Berno Tanner Breakdown of academic impact, for papers by Herbert L. Kotz Breakdown of academic impact, for papers by Yuji Yaginuma Breakdown of academic impact, for papers by Claus Lattrich Breakdown of academic impact, for papers by Qianming Bai Breakdown of academic impact, for papers by Gary L. Goldberg Breakdown of academic impact, for papers by Verena Materna Breakdown of academic impact, for papers by Dineo Khabele Breakdown of academic impact, for papers by Vincenzo Sforza Breakdown of academic impact, for papers by Lin Guo
Rankless by CCL
2026